Tech Company Financing Transactions
Immunotope Funding Round
Immunotope closed a $350 thousand Series B financing round on 6/26/2007. Investors included .
Transaction Overview
Company Name
Announced On
6/26/2007
Transaction Type
Venture Equity
Amount
$350,000
Round
Series B
Investors
No investors have been recorded for this company.
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
3805 Old Easton Road
Doylestown, PA 18902
USA
Doylestown, PA 18902
USA
Phone
Website
Email Address
Overview
IMMUNOTOPE is a clinical stage biotechnology company developing immunotherapy products for the treatment and prevention of cancer and chronic viral infections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Edward Erickson
Chief Operating Officer
Mohan Philip
Chief Scientific Officer
Ramila Philip
Executive Vice President
Lorraine Keller
VP - Bus. Development
Paul Hoegen
Browse more venture capital transactions:
Prev: 6/26/2007: Stion venture capital transaction
Next: 6/26/2007: EGT venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs